Gilead (GILD) Q4 Sovaldi Sales Tracking at $53M - Deutsche Bank
Tweet Send to a Friend
Deutsche Bank maintained a Buy rating on Gilead Sciences (NASDAQ: GILD) with a price target of $95.00. Analyst Robyn Karnauskas ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
